Table of Content

1 Report Overview
1.1 Valsartan Drug Definition
1.2 Market by Type
1.2.1 Global Valsartan Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 40 mg Tablets
1.2.3 80 mg Tablets
1.2.4 160 mg Tablets
1.2.5 320 mg Tablets
1.3 Market Segment by Application
1.3.1 Global Valsartan Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Hypertension
1.3.3 Heart Failure
1.3.4 Heart Attack
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Valsartan Drug Sales
2.1 Global Valsartan Drug Revenue Estimates and Forecasts 2018-2034
2.2 Global Valsartan Drug Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Valsartan Drug Revenue by Region
2.3.1 Global Valsartan Drug Revenue by Region (2018-2023)
2.3.2 Global Valsartan Drug Revenue by Region (2024-2034)
2.4 Global Valsartan Drug Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Valsartan Drug Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Valsartan Drug Sales Quantity by Region
2.6.1 Global Valsartan Drug Sales Quantity by Region (2018-2023)
2.6.2 Global Valsartan Drug Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Valsartan Drug Sales Quantity by Manufacturers
3.1.1 Global Valsartan Drug Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Valsartan Drug Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Valsartan Drug Sales in 2024
3.2 Global Valsartan Drug Revenue by Manufacturers
3.2.1 Global Valsartan Drug Revenue by Manufacturers (2018-2023)
3.2.2 Global Valsartan Drug Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Valsartan Drug Revenue in 2024
3.3 Global Valsartan Drug Sales Price by Manufacturers
3.4 Global Key Players of Valsartan Drug, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Valsartan Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Valsartan Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Valsartan Drug, Product Offered and Application
3.8 Global Key Manufacturers of Valsartan Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Valsartan Drug Sales Quantity by Type
4.1.1 Global Valsartan Drug Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Valsartan Drug Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Valsartan Drug Sales Quantity Market Share by Type (2018-2034)
4.2 Global Valsartan Drug Revenue by Type
4.2.1 Global Valsartan Drug Historical Revenue by Type (2018-2023)
4.2.2 Global Valsartan Drug Forecasted Revenue by Type (2024-2034)
4.2.3 Global Valsartan Drug Revenue Market Share by Type (2018-2034)
4.3 Global Valsartan Drug Price by Type
4.3.1 Global Valsartan Drug Price by Type (2018-2023)
4.3.2 Global Valsartan Drug Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Valsartan Drug Sales Quantity by Application
5.1.1 Global Valsartan Drug Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Valsartan Drug Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Valsartan Drug Sales Quantity Market Share by Application (2018-2034)
5.2 Global Valsartan Drug Revenue by Application
5.2.1 Global Valsartan Drug Historical Revenue by Application (2018-2023)
5.2.2 Global Valsartan Drug Forecasted Revenue by Application (2024-2034)
5.2.3 Global Valsartan Drug Revenue Market Share by Application (2018-2034)
5.3 Global Valsartan Drug Price by Application
5.3.1 Global Valsartan Drug Price by Application (2018-2023)
5.3.2 Global Valsartan Drug Price Forecast by Application (2024-2034)
6 North America
6.1 North America Valsartan Drug Sales by Company
6.1.1 North America Valsartan Drug Revenue by Company (2018-2023)
6.1.2 North America Valsartan Drug Sales Quantity by Company (2018-2023)
6.2 North America Valsartan Drug Market Size by Type
6.2.1 North America Valsartan Drug Sales Quantity by Type (2018-2034)
6.2.2 North America Valsartan Drug Revenue by Type (2018-2034)
6.3 North America Valsartan Drug Market Size by Application
6.3.1 North America Valsartan Drug Sales Quantity by Application (2018-2034)
6.3.2 North America Valsartan Drug Revenue by Application (2018-2034)
6.4 North America Valsartan Drug Market Size by Country
6.4.1 North America Valsartan Drug Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Valsartan Drug Revenue by Country (2018-2034)
6.4.3 North America Valsartan Drug Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Valsartan Drug Sales by Company
7.1.1 Europe Valsartan Drug Sales Quantity by Company (2018-2023)
7.1.2 Europe Valsartan Drug Revenue by Company (2018-2023)
7.2 Europe Valsartan Drug Market Size by Type
7.2.1 Europe Valsartan Drug Sales Quantity by Type (2018-2034)
7.2.2 Europe Valsartan Drug Revenue by Type (2018-2034)
7.3 Europe Valsartan Drug Market Size by Application
7.3.1 Europe Valsartan Drug Sales Quantity by Application (2018-2034)
7.3.2 Europe Valsartan Drug Revenue by Application (2018-2034)
7.4 Europe Valsartan Drug Market Size by Country
7.4.1 Europe Valsartan Drug Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Valsartan Drug Revenue by Country (2018-2034)
7.4.3 Europe Valsartan Drug Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Valsartan Drug Sales by Company
8.1.1 China Valsartan Drug Sales Quantity by Company (2018-2023)
8.1.2 China Valsartan Drug Revenue by Company (2018-2023)
8.2 China Valsartan Drug Market Size by Type
8.2.1 China Valsartan Drug Sales Quantity by Type (2018-2034)
8.2.2 China Valsartan Drug Revenue by Type (2018-2034)
8.3 China Valsartan Drug Market Size by Application
8.3.1 China Valsartan Drug Sales Quantity by Application (2018-2034)
8.3.2 China Valsartan Drug Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Valsartan Drug Sales by Company
9.1.1 APAC Valsartan Drug Sales Quantity by Company (2018-2023)
9.1.2 APAC Valsartan Drug Revenue by Company (2018-2023)
9.2 APAC Valsartan Drug Market Size by Type
9.2.1 APAC Valsartan Drug Sales Quantity by Type (2018-2034)
9.2.2 APAC Valsartan Drug Revenue by Type (2018-2034)
9.3 APAC Valsartan Drug Market Size by Application
9.3.1 APAC Valsartan Drug Sales Quantity by Application (2018-2034)
9.3.2 APAC Valsartan Drug Revenue by Application (2018-2034)
9.4 APAC Valsartan Drug Market Size by Region
9.4.1 APAC Valsartan Drug Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Valsartan Drug Revenue by Region (2018-2034)
9.4.3 APAC Valsartan Drug Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Valsartan Drug Sales by Company
10.1.1 Middle East, Africa and Latin America Valsartan Drug Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Valsartan Drug Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Valsartan Drug Market Size by Type
10.2.1 Middle East, Africa and Latin America Valsartan Drug Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Valsartan Drug Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Valsartan Drug Market Size by Application
10.3.1 Middle East, Africa and Latin America Valsartan Drug Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Valsartan Drug Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Valsartan Drug Market Size by Country
10.4.1 Middle East, Africa and Latin America Valsartan Drug Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Valsartan Drug Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Valsartan Drug Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Overview
11.1.3 Novartis Valsartan Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Novartis Valsartan Drug Products and Services
11.1.5 Novartis Valsartan Drug SWOT Analysis
11.1.6 Novartis Recent Developments
11.2 Sun Pharmaceutical
11.2.1 Sun Pharmaceutical Company Information
11.2.2 Sun Pharmaceutical Overview
11.2.3 Sun Pharmaceutical Valsartan Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Sun Pharmaceutical Valsartan Drug Products and Services
11.2.5 Sun Pharmaceutical Valsartan Drug SWOT Analysis
11.2.6 Sun Pharmaceutical Recent Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva Overview
11.3.3 Teva Valsartan Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Teva Valsartan Drug Products and Services
11.3.5 Teva Valsartan Drug SWOT Analysis
11.3.6 Teva Recent Developments
11.4 Mylan
11.4.1 Mylan Company Information
11.4.2 Mylan Overview
11.4.3 Mylan Valsartan Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Mylan Valsartan Drug Products and Services
11.4.5 Mylan Valsartan Drug SWOT Analysis
11.4.6 Mylan Recent Developments
11.5 Alembic Pharmaceuticals
11.5.1 Alembic Pharmaceuticals Company Information
11.5.2 Alembic Pharmaceuticals Overview
11.5.3 Alembic Pharmaceuticals Valsartan Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Alembic Pharmaceuticals Valsartan Drug Products and Services
11.5.5 Alembic Pharmaceuticals Valsartan Drug SWOT Analysis
11.5.6 Alembic Pharmaceuticals Recent Developments
11.6 Lupin
11.6.1 Lupin Company Information
11.6.2 Lupin Overview
11.6.3 Lupin Valsartan Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Lupin Valsartan Drug Products and Services
11.6.5 Lupin Valsartan Drug SWOT Analysis
11.6.6 Lupin Recent Developments
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Company Information
11.7.2 Aurobindo Pharma Overview
11.7.3 Aurobindo Pharma Valsartan Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Aurobindo Pharma Valsartan Drug Products and Services
11.7.5 Aurobindo Pharma Valsartan Drug SWOT Analysis
11.7.6 Aurobindo Pharma Recent Developments
11.8 Macleods Pharmaceuticals
11.8.1 Macleods Pharmaceuticals Company Information
11.8.2 Macleods Pharmaceuticals Overview
11.8.3 Macleods Pharmaceuticals Valsartan Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Macleods Pharmaceuticals Valsartan Drug Products and Services
11.8.5 Macleods Pharmaceuticals Valsartan Drug SWOT Analysis
11.8.6 Macleods Pharmaceuticals Recent Developments
11.9 HETERO
11.9.1 HETERO Company Information
11.9.2 HETERO Overview
11.9.3 HETERO Valsartan Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 HETERO Valsartan Drug Products and Services
11.9.5 HETERO Valsartan Drug SWOT Analysis
11.9.6 HETERO Recent Developments
11.10 Torrent Pharmaceuticals
11.10.1 Torrent Pharmaceuticals Company Information
11.10.2 Torrent Pharmaceuticals Overview
11.10.3 Torrent Pharmaceuticals Valsartan Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 Torrent Pharmaceuticals Valsartan Drug Products and Services
11.10.5 Torrent Pharmaceuticals Valsartan Drug SWOT Analysis
11.10.6 Torrent Pharmaceuticals Recent Developments
11.11 Huaren Pharmaceutical
11.11.1 Huaren Pharmaceutical Company Information
11.11.2 Huaren Pharmaceutical Overview
11.11.3 Huaren Pharmaceutical Valsartan Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.11.4 Huaren Pharmaceutical Valsartan Drug Products and Services
11.11.5 Huaren Pharmaceutical Recent Developments
11.12 Jubilant Pharma
11.12.1 Jubilant Pharma Company Information
11.12.2 Jubilant Pharma Overview
11.12.3 Jubilant Pharma Valsartan Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.12.4 Jubilant Pharma Valsartan Drug Products and Services
11.12.5 Jubilant Pharma Recent Developments
11.13 Amneal Pharmaceuticals
11.13.1 Amneal Pharmaceuticals Company Information
11.13.2 Amneal Pharmaceuticals Overview
11.13.3 Amneal Pharmaceuticals Valsartan Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.13.4 Amneal Pharmaceuticals Valsartan Drug Products and Services
11.13.5 Amneal Pharmaceuticals Recent Developments
11.14 Zhejiang Huahai Pharmaceutical
11.14.1 Zhejiang Huahai Pharmaceutical Company Information
11.14.2 Zhejiang Huahai Pharmaceutical Overview
11.14.3 Zhejiang Huahai Pharmaceutical Valsartan Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.14.4 Zhejiang Huahai Pharmaceutical Valsartan Drug Products and Services
11.14.5 Zhejiang Huahai Pharmaceutical Recent Developments
11.15 Square Pharmaceuticals
11.15.1 Square Pharmaceuticals Company Information
11.15.2 Square Pharmaceuticals Overview
11.15.3 Square Pharmaceuticals Valsartan Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.15.4 Square Pharmaceuticals Valsartan Drug Products and Services
11.15.5 Square Pharmaceuticals Recent Developments
11.16 Unichem Laboratories
11.16.1 Unichem Laboratories Company Information
11.16.2 Unichem Laboratories Overview
11.16.3 Unichem Laboratories Valsartan Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.16.4 Unichem Laboratories Valsartan Drug Products and Services
11.16.5 Unichem Laboratories Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Valsartan Drug Value Chain Analysis
12.2 Valsartan Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Valsartan Drug Production Mode & Process
12.4 Valsartan Drug Sales and Marketing
12.4.1 Valsartan Drug Sales Channels
12.4.2 Valsartan Drug Distributors
12.5 Valsartan Drug Customers
13 Market Dynamics
13.1 Valsartan Drug Industry Trends
13.2 Valsartan Drug Market Drivers
13.3 Valsartan Drug Market Challenges
13.4 Valsartan Drug Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Valsartan Drug Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of 40 mg Tablets
Table 3. Major Manufacturers of 80 mg Tablets
Table 4. Major Manufacturers of 160 mg Tablets
Table 5. Major Manufacturers of 320 mg Tablets
Table 6. Global Valsartan Drug Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global Valsartan Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Valsartan Drug Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Valsartan Drug Revenue Market Share by Region (2018-2023)
Table 10. Global Valsartan Drug Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Valsartan Drug Revenue Market Share by Region (2024-2034)
Table 12. Global Valsartan Drug Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Units)
Table 13. Global Valsartan Drug Sales by Region (2018-2023) & (K Units)
Table 14. Global Valsartan Drug Sales Market Share by Region (2018-2023)
Table 15. Global Valsartan Drug Sales by Region (2024-2034) & (K Units)
Table 16. Global Valsartan Drug Sales Market Share by Region (2024-2034)
Table 17. Global Valsartan Drug Sales Quantity by Manufacturers (2018-2023) & (K Units)
Table 18. Global Valsartan Drug Sales Quantity Share by Manufacturers (2018-2023)
Table 19. Global Valsartan Drug Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global Valsartan Drug Revenue Share by Manufacturers (2018-2023)
Table 21. Global Valsartan Drug Price by Manufacturers 2018-2023 (USD/Unit)
Table 22. Global Key Players of Valsartan Drug, Industry Ranking, 2021 VS 2024
Table 23. Global Valsartan Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Valsartan Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Valsartan Drug as of 2024)
Table 25. Global Key Manufacturers of Valsartan Drug, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Valsartan Drug, Product Offered and Application
Table 27. Global Key Manufacturers of Valsartan Drug, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Valsartan Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 30. Global Valsartan Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 31. Global Valsartan Drug Sales Quantity Share by Type (2018-2023)
Table 32. Global Valsartan Drug Sales Quantity Share by Type (2024-2034)
Table 33. Global Valsartan Drug Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global Valsartan Drug Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Valsartan Drug Revenue Share by Type (2018-2023)
Table 36. Global Valsartan Drug Revenue Share by Type (2024-2034)
Table 37. Valsartan Drug Price by Type (2018-2023) & (USD/Unit)
Table 38. Global Valsartan Drug Price Forecast by Type (2024-2034) & (USD/Unit)
Table 39. Global Valsartan Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 40. Global Valsartan Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 41. Global Valsartan Drug Sales Quantity Share by Application (2018-2023)
Table 42. Global Valsartan Drug Sales Quantity Share by Application (2024-2034)
Table 43. Global Valsartan Drug Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global Valsartan Drug Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Valsartan Drug Revenue Share by Application (2018-2023)
Table 46. Global Valsartan Drug Revenue Share by Application (2024-2034)
Table 47. Valsartan Drug Price by Application (2018-2023) & (USD/Unit)
Table 48. Global Valsartan Drug Price Forecast by Application (2024-2034) & (USD/Unit)
Table 49. North America Valsartan Drug Revenue by Company (2018-2023) & (US$ Million)
Table 50. North America Valsartan Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 51. North America Valsartan Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 52. North America Valsartan Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 53. North America Valsartan Drug Revenue by Type (2018-2023) & (US$ Million)
Table 54. North America Valsartan Drug Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Valsartan Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 56. North America Valsartan Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 57. North America Valsartan Drug Revenue by Application (2018-2023) & (US$ Million)
Table 58. North America Valsartan Drug Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Valsartan Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 60. North America Valsartan Drug Revenue by Country (2018-2023) & (US$ Million)
Table 61. North America Valsartan Drug Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Valsartan Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 63. North America Valsartan Drug Sales Quantity by Country (2024-2034) & (K Units)
Table 64. Europe Valsartan Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 65. Europe Valsartan Drug Revenue by Company (2018-2023) & (US$ Million)
Table 66. Europe Valsartan Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 67. Europe Valsartan Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 68. Europe Valsartan Drug Revenue by Type (2018-2023) & (US$ Million)
Table 69. Europe Valsartan Drug Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Valsartan Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 71. Europe Valsartan Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 72. Europe Valsartan Drug Revenue by Application (2018-2023) & (US$ Million)
Table 73. Europe Valsartan Drug Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Valsartan Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 75. Europe Valsartan Drug Revenue by Country (2018-2023) & (US$ Million)
Table 76. Europe Valsartan Drug Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Valsartan Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 78. Europe Valsartan Drug Sales Quantity by Country (2024-2034) & (K Units)
Table 79. China Valsartan Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 80. China Valsartan Drug Revenue by Company (2018-2023) & (US$ Million)
Table 81. China Valsartan Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 82. China Valsartan Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 83. China Valsartan Drug Revenue by Type (2018-2023) & (US$ Million)
Table 84. China Valsartan Drug Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Valsartan Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 86. China Valsartan Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 87. China Valsartan Drug Revenue by Application (2018-2023) & (US$ Million)
Table 88. China Valsartan Drug Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Valsartan Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 90. APAC Valsartan Drug Revenue by Company (2018-2023) & (US$ Million)
Table 91. APAC Valsartan Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 92. APAC Valsartan Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 93. APAC Valsartan Drug Revenue by Type (2018-2023) & (US$ Million)
Table 94. APAC Valsartan Drug Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Valsartan Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 96. APAC Valsartan Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 97. APAC Valsartan Drug Revenue by Application (2018-2023) & (US$ Million)
Table 98. APAC Valsartan Drug Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Valsartan Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 100. APAC Valsartan Drug Revenue by Region (2018-2023) & (US$ Million)
Table 101. APAC Valsartan Drug Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Valsartan Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 103. APAC Valsartan Drug Sales Quantity by Region (2024-2034) & (K Units)
Table 104. Middle East, Africa and Latin America Valsartan Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 105. Middle East, Africa and Latin America Valsartan Drug Revenue by Company (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Valsartan Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Middle East, Africa and Latin America Valsartan Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 108. Middle East, Africa and Latin America Valsartan Drug Revenue by Type (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America Valsartan Drug Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Valsartan Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Middle East, Africa and Latin America Valsartan Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 112. Middle East, Africa and Latin America Valsartan Drug Revenue by Application (2018-2023) & (US$ Million)
Table 113. Middle East, Africa and Latin America Valsartan Drug Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Valsartan Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Valsartan Drug Revenue by Country (2018-2023) & (US$ Million)
Table 116. Middle East, Africa and Latin America Valsartan Drug Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Valsartan Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Middle East, Africa and Latin America Valsartan Drug Sales Quantity by Country (2024-2034) & (K Units)
Table 119. Novartis Company Information
Table 120. Novartis Description and Overview
Table 121. Novartis Valsartan Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 122. Novartis Valsartan Drug Product and Services
Table 123. Novartis Valsartan Drug SWOT Analysis
Table 124. Novartis Recent Developments
Table 125. Sun Pharmaceutical Company Information
Table 126. Sun Pharmaceutical Description and Overview
Table 127. Sun Pharmaceutical Valsartan Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 128. Sun Pharmaceutical Valsartan Drug Product and Services
Table 129. Sun Pharmaceutical Valsartan Drug SWOT Analysis
Table 130. Sun Pharmaceutical Recent Developments
Table 131. Teva Company Information
Table 132. Teva Description and Overview
Table 133. Teva Valsartan Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 134. Teva Valsartan Drug Product and Services
Table 135. Teva Valsartan Drug SWOT Analysis
Table 136. Teva Recent Developments
Table 137. Mylan Company Information
Table 138. Mylan Description and Overview
Table 139. Mylan Valsartan Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 140. Mylan Valsartan Drug Product and Services
Table 141. Mylan Valsartan Drug SWOT Analysis
Table 142. Mylan Recent Developments
Table 143. Alembic Pharmaceuticals Company Information
Table 144. Alembic Pharmaceuticals Description and Overview
Table 145. Alembic Pharmaceuticals Valsartan Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 146. Alembic Pharmaceuticals Valsartan Drug Product and Services
Table 147. Alembic Pharmaceuticals Valsartan Drug SWOT Analysis
Table 148. Alembic Pharmaceuticals Recent Developments
Table 149. Lupin Company Information
Table 150. Lupin Description and Overview
Table 151. Lupin Valsartan Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 152. Lupin Valsartan Drug Product and Services
Table 153. Lupin Valsartan Drug SWOT Analysis
Table 154. Lupin Recent Developments
Table 155. Aurobindo Pharma Company Information
Table 156. Aurobindo Pharma Description and Overview
Table 157. Aurobindo Pharma Valsartan Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 158. Aurobindo Pharma Valsartan Drug Product and Services
Table 159. Aurobindo Pharma Valsartan Drug SWOT Analysis
Table 160. Aurobindo Pharma Recent Developments
Table 161. Macleods Pharmaceuticals Company Information
Table 162. Macleods Pharmaceuticals Description and Overview
Table 163. Macleods Pharmaceuticals Valsartan Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 164. Macleods Pharmaceuticals Valsartan Drug Product and Services
Table 165. Macleods Pharmaceuticals Valsartan Drug SWOT Analysis
Table 166. Macleods Pharmaceuticals Recent Developments
Table 167. HETERO Company Information
Table 168. HETERO Description and Overview
Table 169. HETERO Valsartan Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 170. HETERO Valsartan Drug Product and Services
Table 171. HETERO Valsartan Drug SWOT Analysis
Table 172. HETERO Recent Developments
Table 173. Torrent Pharmaceuticals Company Information
Table 174. Torrent Pharmaceuticals Description and Overview
Table 175. Torrent Pharmaceuticals Valsartan Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 176. Torrent Pharmaceuticals Valsartan Drug Product and Services
Table 177. Torrent Pharmaceuticals Valsartan Drug SWOT Analysis
Table 178. Torrent Pharmaceuticals Recent Developments
Table 179. Huaren Pharmaceutical Company Information
Table 180. Huaren Pharmaceutical Description and Overview
Table 181. Huaren Pharmaceutical Valsartan Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 182. Huaren Pharmaceutical Valsartan Drug Product and Services
Table 183. Huaren Pharmaceutical Recent Developments
Table 184. Jubilant Pharma Company Information
Table 185. Jubilant Pharma Description and Overview
Table 186. Jubilant Pharma Valsartan Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 187. Jubilant Pharma Valsartan Drug Product and Services
Table 188. Jubilant Pharma Recent Developments
Table 189. Amneal Pharmaceuticals Company Information
Table 190. Amneal Pharmaceuticals Description and Overview
Table 191. Amneal Pharmaceuticals Valsartan Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 192. Amneal Pharmaceuticals Valsartan Drug Product and Services
Table 193. Amneal Pharmaceuticals Recent Developments
Table 194. Zhejiang Huahai Pharmaceutical Company Information
Table 195. Zhejiang Huahai Pharmaceutical Description and Overview
Table 196. Zhejiang Huahai Pharmaceutical Valsartan Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 197. Zhejiang Huahai Pharmaceutical Valsartan Drug Product and Services
Table 198. Zhejiang Huahai Pharmaceutical Recent Developments
Table 199. Square Pharmaceuticals Company Information
Table 200. Square Pharmaceuticals Description and Overview
Table 201. Square Pharmaceuticals Valsartan Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 202. Square Pharmaceuticals Valsartan Drug Product and Services
Table 203. Square Pharmaceuticals Recent Developments
Table 204. Unichem Laboratories Company Information
Table 205. Unichem Laboratories Description and Overview
Table 206. Unichem Laboratories Valsartan Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 207. Unichem Laboratories Valsartan Drug Product and Services
Table 208. Unichem Laboratories Recent Developments
Table 209. Key Raw Materials Lists
Table 210. Raw Materials Key Suppliers Lists
Table 211. Valsartan Drug Distributors List
Table 212. Valsartan Drug Customers List
Table 213. Valsartan Drug Market Trends
Table 214. Valsartan Drug Market Drivers
Table 215. Valsartan Drug Market Challenges
Table 216. Valsartan Drug Market Restraints
Table 217. Research Programs/Design for This Report
Table 218. Key Data Information from Secondary Sources
Table 219. Key Data Information from Primary Sources
List of Figures
Figure 1. Valsartan Drug Product Picture
Figure 2. Global Valsartan Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Valsartan Drug Market Share by Type in 2024 & 2034
Figure 4. 40 mg Tablets Product Picture
Figure 5. 80 mg Tablets Product Picture
Figure 6. 160 mg Tablets Product Picture
Figure 7. 320 mg Tablets Product Picture
Figure 8. Global Valsartan Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 9. Global Valsartan Drug Market Share by Application in 2024 & 2034
Figure 10. Hypertension
Figure 11. Heart Failure
Figure 12. Heart Attack
Figure 13. Valsartan Drug Report Years Considered
Figure 14. Global Valsartan Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 15. Global Valsartan Drug Revenue 2018-2034 (US$ Million)
Figure 16. Global Valsartan Drug Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 17. Global Valsartan Drug Sales Quantity 2018-2034 (K Units)
Figure 18. Global Valsartan Drug Sales Quantity Market Share by Region (2018-2023)
Figure 19. Global Valsartan Drug Sales Quantity Market Share by Region (2024-2034)
Figure 20. North America Valsartan Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 21. North America Valsartan Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 22. Europe Valsartan Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 23. Europe Valsartan Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 24. China Valsartan Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. China Valsartan Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 26. APAC Valsartan Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. APAC Valsartan Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Valsartan Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 29. Middle East, Africa and Latin America Valsartan Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 30. The Top 10 and Top 5 Players Market Share by Valsartan Drug Sales Quantity in 2024
Figure 31. The Top 10 and Top 5 Players Market Share by Valsartan Drug Revenue in 2024
Figure 32. Valsartan Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 33. Global Valsartan Drug Sales Quantity Market Share by Type (2018-2034)
Figure 34. Global Valsartan Drug Revenue Market Share by Type (2018-2034)
Figure 35. Global Valsartan Drug Sales Quantity Market Share by Application (2018-2034)
Figure 36. Global Valsartan Drug Revenue Market Share by Application (2018-2034)
Figure 37. North America Valsartan Drug Revenue Market Share by Company in 2024
Figure 38. North America Valsartan Drug Sales Quantity Market Share by Company in 2024
Figure 39. North America Valsartan Drug Sales Quantity Market Share by Type (2018-2034)
Figure 40. North America Valsartan Drug Revenue Market Share by Type (2018-2034)
Figure 41. North America Valsartan Drug Sales Quantity Market Share by Application (2018-2034)
Figure 42. North America Valsartan Drug Revenue Market Share by Application (2018-2034)
Figure 43. North America Valsartan Drug Revenue Share by Country (2018-2034)
Figure 44. North America Valsartan Drug Sales Quantity Share by Country (2018-2034)
Figure 45. U.S. Valsartan Drug Revenue (2018-2034) & (US$ Million)
Figure 46. Canada Valsartan Drug Revenue (2018-2034) & (US$ Million)
Figure 47. Europe Valsartan Drug Sales Quantity Market Share by Company in 2024
Figure 48. Europe Valsartan Drug Revenue Market Share by Company in 2024
Figure 49. Europe Valsartan Drug Sales Quantity Market Share by Type (2018-2034)
Figure 50. Europe Valsartan Drug Revenue Market Share by Type (2018-2034)
Figure 51. Europe Valsartan Drug Sales Quantity Market Share by Application (2018-2034)
Figure 52. Europe Valsartan Drug Revenue Market Share by Application (2018-2034)
Figure 53. Europe Valsartan Drug Revenue Share by Country (2018-2034)
Figure 54. Europe Valsartan Drug Sales Quantity Share by Country (2018-2034)
Figure 55. Germany Valsartan Drug Revenue (2018-2034) & (US$ Million)
Figure 56. France Valsartan Drug Revenue (2018-2034) & (US$ Million)
Figure 57. U.K. Valsartan Drug Revenue (2018-2034) & (US$ Million)
Figure 58. Italy Valsartan Drug Revenue (2018-2034) & (US$ Million)
Figure 59. Russia Valsartan Drug Revenue (2018-2034) & (US$ Million)
Figure 60. China Valsartan Drug Sales Quantity Market Share by Company in 2024
Figure 61. China Valsartan Drug Revenue Market Share by Company in 2024
Figure 62. China Valsartan Drug Sales Quantity Market Share by Type (2018-2034)
Figure 63. China Valsartan Drug Revenue Market Share by Type (2018-2034)
Figure 64. China Valsartan Drug Sales Quantity Market Share by Application (2018-2034)
Figure 65. China Valsartan Drug Revenue Market Share by Application (2018-2034)
Figure 66. APAC Valsartan Drug Sales Quantity Market Share by Company in 2024
Figure 67. APAC Valsartan Drug Revenue Market Share by Company in 2024
Figure 68. APAC Valsartan Drug Sales Quantity Market Share by Type (2018-2034)
Figure 69. APAC Valsartan Drug Revenue Market Share by Type (2018-2034)
Figure 70. APAC Valsartan Drug Sales Quantity Market Share by Application (2018-2034)
Figure 71. APAC Valsartan Drug Revenue Market Share by Application (2018-2034)
Figure 72. APAC Valsartan Drug Revenue Share by Region (2018-2034)
Figure 73. APAC Valsartan Drug Sales Quantity Share by Region (2018-2034)
Figure 74. Japan Valsartan Drug Revenue (2018-2034) & (US$ Million)
Figure 75. South Korea Valsartan Drug Revenue (2018-2034) & (US$ Million)
Figure 76. China Taiwan Valsartan Drug Revenue (2018-2034) & (US$ Million)
Figure 77. Southeast Asia Valsartan Drug Revenue (2018-2034) & (US$ Million)
Figure 78. India Valsartan Drug Revenue (2018-2034) & (US$ Million)
Figure 79. Middle East, Africa and Latin America Valsartan Drug Sales Quantity Market Share by Company in 2024
Figure 80. Middle East, Africa and Latin America Valsartan Drug Revenue Market Share by Company in 2024
Figure 81. Middle East, Africa and Latin America Valsartan Drug Sales Quantity Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Valsartan Drug Revenue Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Valsartan Drug Sales Quantity Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Valsartan Drug Revenue Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Valsartan Drug Sales Quantity Share by Country (2018-2034)
Figure 86. Middle East, Africa and Latin America Valsartan Drug Revenue Share by Country (2018-2034)
Figure 87. Brazil Valsartan Drug Revenue (2018-2034) & (US$ Million)
Figure 88. Mexico Valsartan Drug Revenue (2018-2034) & (US$ Million)
Figure 89. Turkey Valsartan Drug Revenue (2018-2034) & (US$ Million)
Figure 90. Israel Valsartan Drug Revenue (2018-2034) & (US$ Million)
Figure 91. GCC Countries Valsartan Drug Revenue (2018-2034) & (US$ Million)
Figure 92. Valsartan Drug Value Chain
Figure 93. Valsartan Drug Production Process
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed